Lung cancer is one of the leading causes of cancer-related deaths among women globally. Since 1987 in the United States, it has surpassed breast cancer as the top cause of cancer deaths in females. In India, the incidence of lung cancer in women is steadily rising, becoming a major public health concern. According to the National Cancer Registry Programme (NCRP) for 2012–2016, lung cancer accounts for 6.2% of all cancer cases in Indian women.
The highest incidence rate is seen in Aizawl district, Mizoram, at 27.9 per 100,000, followed by the state of Mizoram at 18.0 per 100,000. Metropolitan cities like Bengaluru, Chennai, Delhi, and Mumbai have shown an upward trend in cases from 1982 to 2016. Worryingly, the age-adjusted lung cancer incidence among females is closing the gap with that of males, with approximately 32% of cases occurring in the 55–64 age group.
One of the most surprising trends is that over two-thirds of female lung cancer patients in India are non-smokers. This has created a dangerous bias: healthcare providers often do not suspect lung cancer in non-smoking women, especially if they are younger and otherwise healthy. In such cases, symptoms are mistaken for asthma, allergies, or even anxiety, delaying vital diagnosis and treatment.
Lung cancer in non-smoker women often presents as adenocarcinoma with EGFR gene mutations. These genetic differences mean treatments like EGFR tyrosine kinase inhibitors (e.g., gefitinib, erlotinib) may work better than traditional chemotherapy. In contrast, smokers more often develop squamous cell carcinoma or small cell lung cancer, linked to tobacco carcinogens and requiring different treatment approaches.
Many of these symptoms are misattributed to minor conditions, causing a significant delay in diagnosis.
Risk Factor | Women (Non-Smokers) | Men (Smokers) |
---|---|---|
Smoking | Lower prevalence | High prevalence |
Air Pollution | High impact | Moderate impact |
Biomass Fuel Exposure | Significant risk | Minimal risk |
A 52-year-old non-smoker woman from Delhi had a mild cough for two months, which was initially treated as bronchitis. Only after a CT scan was performed did doctors discover adenocarcinoma in an early stage, allowing successful targeted therapy. This case highlights why persistent symptoms should never be ignored.
Yes, a significant percentage of women with lung cancer have never smoked, with environmental and genetic factors playing key roles.
Chronic cough, unexplained fatigue, and shortness of breath are common early indicators that should be investigated promptly.
Treatments often include targeted therapies if genetic mutations like EGFR are present, along with surgery or radiation when applicable.
Lung cancer in women is not just a smoker’s disease. Misdiagnosis due to symptom overlap with common illnesses, combined with societal and biological factors, delays treatment. Raising awareness, improving early detection, and tailoring treatment approaches for women can significantly improve survival rates.
No comments yet. Be the first to comment!